Global Super Generics Market Growth (Status and Outlook) 2025-2031

September 2025 | 85 pages | ID: GB966C7032DCEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to this study, the global Super Generics market size will reach US$ million by 2031.

The huge cost of drug development and the time overruns to develop new therapeutics have hindered innovation in the drug research and development space by promoting companies to find alternatives to maintain patent protection for a given brand. Super generics or modified therapeutic entities are an excellent form of a given generic drug molecule, which has better patient compliance and therapeutic effect than existing generic drugs.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Super Generics Industry Forecast” looks at past sales and reviews total world Super Generics sales in 2024, providing a comprehensive analysis by region and market sector of projected Super Generics sales for 2025 through 2031. With Super Generics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Super Generics industry.

This Insight Report provides a comprehensive analysis of the global Super Generics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Super Generics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Super Generics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Super Generics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Super Generics.

This report presents a comprehensive overview, market shares, and growth opportunities of Super Generics market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • Oral
  • Injectable
  • Others
Segmentation by Application:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Sun Pharmaceutical Industries
  • Meda Pharmaceuticals
  • Taiwan Liposome Company
  • Dr. Reddy’s Laboratories
  • Allergan
  • Teva Pharmaceutical
  • Celgene Corporation
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Super Generics Market Size (2020-2031)
  2.1.2 Super Generics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Super Generics by Country/Region (2020, 2024 & 2031)
2.2 Super Generics Segment by Type
  2.2.1 Oral
  2.2.2 Injectable
  2.2.3 Others
2.3 Super Generics Market Size by Type
  2.3.1 Super Generics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Super Generics Market Size Market Share by Type (2020-2025)
2.4 Super Generics Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Retail Pharmacies
  2.4.3 Online Pharmacies
2.5 Super Generics Market Size by Application
  2.5.1 Super Generics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Super Generics Market Size Market Share by Application (2020-2025)

3 SUPER GENERICS MARKET SIZE BY PLAYER

3.1 Super Generics Market Size Market Share by Player
  3.1.1 Global Super Generics Revenue by Player (2020-2025)
  3.1.2 Global Super Generics Revenue Market Share by Player (2020-2025)
3.2 Global Super Generics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 SUPER GENERICS BY REGION

4.1 Super Generics Market Size by Region (2020-2025)
4.2 Global Super Generics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Super Generics Market Size Growth (2020-2025)
4.4 APAC Super Generics Market Size Growth (2020-2025)
4.5 Europe Super Generics Market Size Growth (2020-2025)
4.6 Middle East & Africa Super Generics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Super Generics Market Size by Country (2020-2025)
5.2 Americas Super Generics Market Size by Type (2020-2025)
5.3 Americas Super Generics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Super Generics Market Size by Region (2020-2025)
6.2 APAC Super Generics Market Size by Type (2020-2025)
6.3 APAC Super Generics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Super Generics Market Size by Country (2020-2025)
7.2 Europe Super Generics Market Size by Type (2020-2025)
7.3 Europe Super Generics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Super Generics by Region (2020-2025)
8.2 Middle East & Africa Super Generics Market Size by Type (2020-2025)
8.3 Middle East & Africa Super Generics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL SUPER GENERICS MARKET FORECAST

10.1 Global Super Generics Forecast by Region (2026-2031)
  10.1.1 Global Super Generics Forecast by Region (2026-2031)
  10.1.2 Americas Super Generics Forecast
  10.1.3 APAC Super Generics Forecast
  10.1.4 Europe Super Generics Forecast
  10.1.5 Middle East & Africa Super Generics Forecast
10.2 Americas Super Generics Forecast by Country (2026-2031)
  10.2.1 United States Market Super Generics Forecast
  10.2.2 Canada Market Super Generics Forecast
  10.2.3 Mexico Market Super Generics Forecast
  10.2.4 Brazil Market Super Generics Forecast
10.3 APAC Super Generics Forecast by Region (2026-2031)
  10.3.1 China Super Generics Market Forecast
  10.3.2 Japan Market Super Generics Forecast
  10.3.3 Korea Market Super Generics Forecast
  10.3.4 Southeast Asia Market Super Generics Forecast
  10.3.5 India Market Super Generics Forecast
  10.3.6 Australia Market Super Generics Forecast
10.4 Europe Super Generics Forecast by Country (2026-2031)
  10.4.1 Germany Market Super Generics Forecast
  10.4.2 France Market Super Generics Forecast
  10.4.3 UK Market Super Generics Forecast
  10.4.4 Italy Market Super Generics Forecast
  10.4.5 Russia Market Super Generics Forecast
10.5 Middle East & Africa Super Generics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Super Generics Forecast
  10.5.2 South Africa Market Super Generics Forecast
  10.5.3 Israel Market Super Generics Forecast
  10.5.4 Turkey Market Super Generics Forecast
10.6 Global Super Generics Forecast by Type (2026-2031)
10.7 Global Super Generics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Super Generics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Sun Pharmaceutical Industries
  11.1.1 Sun Pharmaceutical Industries Company Information
  11.1.2 Sun Pharmaceutical Industries Super Generics Product Offered
  11.1.3 Sun Pharmaceutical Industries Super Generics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Sun Pharmaceutical Industries Main Business Overview
  11.1.5 Sun Pharmaceutical Industries Latest Developments
11.2 Meda Pharmaceuticals
  11.2.1 Meda Pharmaceuticals Company Information
  11.2.2 Meda Pharmaceuticals Super Generics Product Offered
  11.2.3 Meda Pharmaceuticals Super Generics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Meda Pharmaceuticals Main Business Overview
  11.2.5 Meda Pharmaceuticals Latest Developments
11.3 Taiwan Liposome Company
  11.3.1 Taiwan Liposome Company Company Information
  11.3.2 Taiwan Liposome Company Super Generics Product Offered
  11.3.3 Taiwan Liposome Company Super Generics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Taiwan Liposome Company Main Business Overview
  11.3.5 Taiwan Liposome Company Latest Developments
11.4 Dr. Reddy’s Laboratories
  11.4.1 Dr. Reddy’s Laboratories Company Information
  11.4.2 Dr. Reddy’s Laboratories Super Generics Product Offered
  11.4.3 Dr. Reddy’s Laboratories Super Generics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Dr. Reddy’s Laboratories Main Business Overview
  11.4.5 Dr. Reddy’s Laboratories Latest Developments
11.5 Allergan
  11.5.1 Allergan Company Information
  11.5.2 Allergan Super Generics Product Offered
  11.5.3 Allergan Super Generics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Allergan Main Business Overview
  11.5.5 Allergan Latest Developments
11.6 Teva Pharmaceutical
  11.6.1 Teva Pharmaceutical Company Information
  11.6.2 Teva Pharmaceutical Super Generics Product Offered
  11.6.3 Teva Pharmaceutical Super Generics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Teva Pharmaceutical Main Business Overview
  11.6.5 Teva Pharmaceutical Latest Developments
11.7 Celgene Corporation
  11.7.1 Celgene Corporation Company Information
  11.7.2 Celgene Corporation Super Generics Product Offered
  11.7.3 Celgene Corporation Super Generics Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Celgene Corporation Main Business Overview
  11.7.5 Celgene Corporation Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. Super Generics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Super Generics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injectable
Table 5. Major Players of Others
Table 6. Super Generics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Super Generics Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Super Generics Market Size Market Share by Type (2020-2025)
Table 9. Super Generics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Super Generics Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Super Generics Market Size Market Share by Application (2020-2025)
Table 12. Global Super Generics Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Super Generics Revenue Market Share by Player (2020-2025)
Table 14. Super Generics Key Players Head office and Products Offered
Table 15. Super Generics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Super Generics Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Super Generics Market Size Market Share by Region (2020-2025)
Table 20. Global Super Generics Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Super Generics Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Super Generics Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Super Generics Market Size Market Share by Country (2020-2025)
Table 24. Americas Super Generics Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Super Generics Market Size Market Share by Type (2020-2025)
Table 26. Americas Super Generics Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Super Generics Market Size Market Share by Application (2020-2025)
Table 28. APAC Super Generics Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Super Generics Market Size Market Share by Region (2020-2025)
Table 30. APAC Super Generics Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Super Generics Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Super Generics Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Super Generics Market Size Market Share by Country (2020-2025)
Table 34. Europe Super Generics Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Super Generics Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Super Generics Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Super Generics Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Super Generics Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Super Generics
Table 40. Key Market Challenges & Risks of Super Generics
Table 41. Key Industry Trends of Super Generics
Table 42. Global Super Generics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Super Generics Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Super Generics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Super Generics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Sun Pharmaceutical Industries Details, Company Type, Super Generics Area Served and Its Competitors
Table 47. Sun Pharmaceutical Industries Super Generics Product Offered
Table 48. Sun Pharmaceutical Industries Super Generics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Sun Pharmaceutical Industries Main Business
Table 50. Sun Pharmaceutical Industries Latest Developments
Table 51. Meda Pharmaceuticals Details, Company Type, Super Generics Area Served and Its Competitors
Table 52. Meda Pharmaceuticals Super Generics Product Offered
Table 53. Meda Pharmaceuticals Super Generics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Meda Pharmaceuticals Main Business
Table 55. Meda Pharmaceuticals Latest Developments
Table 56. Taiwan Liposome Company Details, Company Type, Super Generics Area Served and Its Competitors
Table 57. Taiwan Liposome Company Super Generics Product Offered
Table 58. Taiwan Liposome Company Super Generics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Taiwan Liposome Company Main Business
Table 60. Taiwan Liposome Company Latest Developments
Table 61. Dr. Reddy’s Laboratories Details, Company Type, Super Generics Area Served and Its Competitors
Table 62. Dr. Reddy’s Laboratories Super Generics Product Offered
Table 63. Dr. Reddy’s Laboratories Super Generics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Dr. Reddy’s Laboratories Main Business
Table 65. Dr. Reddy’s Laboratories Latest Developments
Table 66. Allergan Details, Company Type, Super Generics Area Served and Its Competitors
Table 67. Allergan Super Generics Product Offered
Table 68. Allergan Super Generics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Allergan Main Business
Table 70. Allergan Latest Developments
Table 71. Teva Pharmaceutical Details, Company Type, Super Generics Area Served and Its Competitors
Table 72. Teva Pharmaceutical Super Generics Product Offered
Table 73. Teva Pharmaceutical Super Generics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Teva Pharmaceutical Main Business
Table 75. Teva Pharmaceutical Latest Developments
Table 76. Celgene Corporation Details, Company Type, Super Generics Area Served and Its Competitors
Table 77. Celgene Corporation Super Generics Product Offered
Table 78. Celgene Corporation Super Generics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Celgene Corporation Main Business
Table 80. Celgene Corporation Latest Developments

LIST OF FIGURES

Figure 1. Super Generics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Super Generics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Super Generics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Super Generics Sales Market Share by Country/Region (2024)
Figure 8. Super Generics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Super Generics Market Size Market Share by Type in 2024
Figure 10. Super Generics in Hospital Pharmacies
Figure 11. Global Super Generics Market: Hospital Pharmacies (2020-2025) & ($ millions)
Figure 12. Super Generics in Retail Pharmacies
Figure 13. Global Super Generics Market: Retail Pharmacies (2020-2025) & ($ millions)
Figure 14. Super Generics in Online Pharmacies
Figure 15. Global Super Generics Market: Online Pharmacies (2020-2025) & ($ millions)
Figure 16. Global Super Generics Market Size Market Share by Application in 2024
Figure 17. Global Super Generics Revenue Market Share by Player in 2024
Figure 18. Global Super Generics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Super Generics Market Size 2020-2025 ($ millions)
Figure 20. APAC Super Generics Market Size 2020-2025 ($ millions)
Figure 21. Europe Super Generics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Super Generics Market Size 2020-2025 ($ millions)
Figure 23. Americas Super Generics Value Market Share by Country in 2024
Figure 24. United States Super Generics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Super Generics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Super Generics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Super Generics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Super Generics Market Size Market Share by Region in 2024
Figure 29. APAC Super Generics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Super Generics Market Size Market Share by Application (2020-2025)
Figure 31. China Super Generics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Super Generics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Super Generics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Super Generics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Super Generics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Super Generics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Super Generics Market Size Market Share by Country in 2024
Figure 38. Europe Super Generics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Super Generics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Super Generics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Super Generics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Super Generics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Super Generics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Super Generics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Super Generics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Super Generics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Super Generics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Super Generics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Super Generics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Super Generics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Super Generics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Super Generics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Super Generics Market Size 2026-2031 ($ millions)
Figure 54. APAC Super Generics Market Size 2026-2031 ($ millions)
Figure 55. Europe Super Generics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Super Generics Market Size 2026-2031 ($ millions)
Figure 57. United States Super Generics Market Size 2026-2031 ($ millions)
Figure 58. Canada Super Generics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Super Generics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Super Generics Market Size 2026-2031 ($ millions)
Figure 61. China Super Generics Market Size 2026-2031 ($ millions)
Figure 62. Japan Super Generics Market Size 2026-2031 ($ millions)
Figure 63. Korea Super Generics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Super Generics Market Size 2026-2031 ($ millions)
Figure 65. India Super Generics Market Size 2026-2031 ($ millions)
Figure 66. Australia Super Generics Market Size 2026-2031 ($ millions)
Figure 67. Germany Super Generics Market Size 2026-2031 ($ millions)
Figure 68. France Super Generics Market Size 2026-2031 ($ millions)
Figure 69. UK Super Generics Market Size 2026-2031 ($ millions)
Figure 70. Italy Super Generics Market Size 2026-2031 ($ millions)
Figure 71. Russia Super Generics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Super Generics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Super Generics Market Size 2026-2031 ($ millions)
Figure 74. Israel Super Generics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Super Generics Market Size 2026-2031 ($ millions)
Figure 76. Global Super Generics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Super Generics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Super Generics Market Size 2026-2031 ($ millions)


More Publications